Next Generation Sequencing (NGS) for Influenza Vaccine Development
A new approach to seasonal flu vaccine development
In this new podcast episode, Q2 Solutions experts Wayne Hogrefe from our Vaccine Laboratory and Pat Hurban from our Genomics Laboratory discuss a new approach to influenza vaccine development: Next Generation Sequencing (NGS).